US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ORUKA THERAPEUTICS INC

102.42

-5.5400-5.13%

Post-market: 102.500.0800+0.08%17:08 EDT

Volume:992.19K

Turnover:101.97M

Market Cap:6.78B

PE:-50.60

High:107.23

Open:106.75

Low:100.64

Close:107.96

52wk High:115.52

52wk Low:14.34

Shares:66.21M

Float Shares:56.65M

Volume Ratio:1.21

T/O Rate:1.75%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0242

EPS(LYR):-1.8483

ROE:-18.23%

ROA:-12.95%

PB:6.10

PE(LYR):-55.41

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE -Organon, Verizon, Core Scientific

Top Premarket Gainers

MT Newswires Live

Oruka Therapeutics Shares Gain on Positive Psoriasis-Treatment Results

Oruka Therapeutics up 36.2% Premarket After Psoriasis Drug Meets Main Goal of Mid-Stage Study

THOMSON REUTERS

Oruka Therapeutics' psoriasis drug meets main goal of mid-stage study

Oruka Therapeutics Inc - Orka-001 Shows Favorable Safety Profile Consistent With Il-23P19 Class

THOMSON REUTERS

Oruka Therapeutics Announces Positive Week 16 Data for Orka-001 From the Ongoing Everlast-a Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis

THOMSON REUTERS

Oruka Therapeutics to report Week 16 ORKA-001 EVERLAST-A Phase 2a data April 27

Assessing Oruka Therapeutics (ORKA) Valuation After A Sharp Multi Month Share Price Rally

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA) and Praxis Precision Medicines (PRAX)

ORKA-002 Psoriasis Trial Progress: What Oruka’s New Phase 2 Update Means for Investors

Oruka Therapeutics announces annual shareholder meeting

Oruka Therapeutics CMO Joana Goncalves disposes of shares worth $462,968

Oruka Therapeutics Inc : Wedbush Raises Target Price to $85 From $45

THOMSON REUTERS

Analysts’ Top Healthcare Picks: Oruka Therapeutics (ORKA), Spyre Therapeutics (SYRE)

Oruka Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $70 From $40

THOMSON REUTERS

This Startup's Psoriasis Drug Studies Have Lifted Its Stock -- Barrons.com

Analysts Are Bullish on These Healthcare Stocks: Cannara Biotech (LOVFF), Oruka Therapeutics (ORKA)

UBS Sticks to Its Buy Rating for Oruka Therapeutics (ORKA)

Does Oruka Therapeutics' (ORKA) $1 Billion Shelf Plan Reframe Its Long-Term Capital Strategy?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ORKA/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":102.42,"timestamp":1787601600000,"preClose":107.96,"halted":0,"volume":992190,"hourTrading":{"tag":"盘后","latestPrice":102.5,"preClose":102.42,"latestTime":"17:08 EDT","volume":20695,"amount":2119581.382625,"timestamp":1787605704906,"change":0.08,"changeRate":0.000781,"amplitude":0.008239},"delay":0,"changeRate":-0.051315301963690184,"floatShares":56648688,"shares":66209699,"eps":-2.024183,"marketStatus":"Post-Mkt","change":-5.54,"latestTime":"08-24 17:57:05 EDT","open":106.75,"high":107.225,"low":100.64,"amount":101965008.85655999,"amplitude":0.060995,"askPrice":108.45,"askSize":348,"bidPrice":77.74,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.024183,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":107.96,"preHourTrading":{"tag":"盘前","latestPrice":107.08,"preClose":107.96,"latestTime":"09:29 EDT","volume":657,"amount":70404.84270000001,"timestamp":1787578199999,"change":-0.88,"changeRate":-0.008151,"amplitude":0.058911},"postHourTrading":{"tag":"盘后","latestPrice":102.5,"preClose":102.42,"latestTime":"17:08 EDT","volume":20695,"amount":2119581.382625,"timestamp":1787605704906,"change":0.08,"changeRate":0.000781,"amplitude":0.008239},"volumeRatio":1.20771,"impliedVol":0.967,"impliedVolPercentile":0.5498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":56648688,"roa":"-12.95%","roe":"-18.23%","lyrEps":-1.84833,"volumeRatio":1.20771,"shares":66209699,"dividePrice":0,"high":107.225,"amplitude":0.060995,"preClose":107.96,"low":100.64,"week52Low":14.34,"pbRate":"6.10","week52High":115.515,"institutionHeld":0.9307,"latestPrice":102.42,"committee":-0.553571,"eps":-2.024183,"divideRate":0,"volume":992190,"delay":0,"ttmEps":-2.024183,"open":106.75,"prevYearClose":30.31,"prevWeekClose":107.96,"prevMonthClose":96.51,"prevQuarterClose":95.17,"fiveDayClose":112.66,"twentyDayClose":90.2,"sixtyDayClose":57.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"ORKA","fiscalQuarterEnding":"2026/06","expectedEps":-0.49,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2026-05-13","symbol":"ORKA","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2026-03-12","symbol":"ORKA","fiscalQuarterEnding":"2025/12","expectedEps":-0.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-11-12","symbol":"ORKA","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":14,"updateTime":1767758400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2026-08-21","current":-50.803213,"percent":0.019231,"low":-56.341471,"twenty":-31.638621,"median":-12.55157,"eighty":-4.687203,"high":-2.779284,"avg":-17.021481,"sd":14.796983,"marketCap":6942749037},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355},{"date":"2025-05-02","current":-4.136132,"twenty":-4.747739,"median":-4.214018,"eighty":-3.521247,"marketCap":377774745},{"date":"2025-05-09","current":-3.996758,"twenty":-4.714945,"median":-4.198946,"eighty":-3.605691,"marketCap":365044972},{"date":"2025-05-16","current":-3.364967,"twenty":-4.682151,"median":-4.136132,"eighty":-3.605691,"marketCap":354187224},{"date":"2025-05-23","current":-3.980336,"twenty":-4.607544,"median":-4.002451,"eighty":-3.625269,"marketCap":418959306},{"date":"2025-05-30","current":-4.215101,"twenty":-4.558354,"median":-4.038702,"eighty":-3.660839,"marketCap":443670043},{"date":"2025-06-06","current":-4.336041,"twenty":-4.541137,"median":-4.079934,"eighty":-3.705732,"marketCap":456399816},{"date":"2025-06-13","current":-4.57792,"twenty":-4.558354,"median":-4.136132,"eighty":-3.769048,"marketCap":481859363},{"date":"2025-06-20","current":-4.261343,"twenty":-4.543597,"median":-4.170639,"eighty":-3.777968,"marketCap":448537309},{"date":"2025-06-27","current":-4.136846,"twenty":-4.523383,"median":-4.154632,"eighty":-3.785238,"marketCap":435433131},{"date":"2025-07-03","current":-4.48188,"twenty":-4.48188,"median":-4.154632,"eighty":-3.808193,"marketCap":471750426},{"date":"2025-07-11","current":-5.004766,"twenty":-4.566552,"median":-4.184867,"eighty":-3.812292,"marketCap":526787975},{"date":"2025-07-18","current":-5.463625,"twenty":-4.701827,"median":-4.197316,"eighty":-3.861483,"marketCap":575086233},{"date":"2025-07-25","current":-5.061679,"twenty":-4.767415,"median":-4.21456,"eighty":-3.877182,"marketCap":532778457},{"date":"2025-08-01","current":-4.834028,"twenty":-4.898055,"median":-4.257786,"eighty":-3.894967,"marketCap":508816530},{"date":"2025-08-08","current":-4.862484,"twenty":-4.898591,"median":-4.281656,"eighty":-3.898524,"marketCap":511811771},{"date":"2025-08-15","current":-5.221398,"twenty":-4.905169,"median":-4.336041,"eighty":-3.910674,"marketCap":561761175},{"date":"2025-08-22","current":-5.148299,"twenty":-5.001209,"median":-4.36364,"eighty":-3.910674,"marketCap":553896518},{"date":"2025-08-29","current":-5.315383,"twenty":-5.050833,"median":-4.460538,"eighty":-3.918873,"marketCap":571872876},{"date":"2025-09-05","current":-5.210955,"twenty":-5.062675,"median":-4.474766,"eighty":-3.936742,"marketCap":560637652},{"date":"2025-09-12","current":-5.621705,"twenty":-5.07235,"median":-4.48188,"eighty":-3.943016,"marketCap":604829531},{"date":"2025-09-19","current":-5.771385,"twenty":-5.152476,"median":-4.546056,"eighty":-3.972962,"marketCap":620933352},{"date":"2025-09-26","current":-5.238803,"twenty":-5.191462,"median":-4.609934,"eighty":-3.980356,"marketCap":563633712},{"date":"2025-10-03","current":-6.676428,"twenty":-5.243928,"median":-4.669033,"eighty":-3.986032,"marketCap":718305289},{"date":"2025-10-10","current":-11.49024,"twenty":-5.309118,"median":-4.714571,"eighty":-3.994896,"marketCap":1236215032},{"date":"2025-10-17","current":-11.944453,"twenty":-5.339054,"median":-4.762887,"eighty":-3.996758,"marketCap":1285083024},{"date":"2025-10-24","current":-12.200791,"twenty":-5.382217,"median":-4.835807,"eighty":-4.005866,"marketCap":1312661989},{"date":"2025-10-31","current":-12.641513,"twenty":-5.468786,"median":-4.862484,"eighty":-4.057038,"marketCap":1360078456},{"date":"2025-11-07","current":-12.717965,"twenty":-5.593858,"median":-4.890941,"eighty":-4.0778,"marketCap":1368303762},{"date":"2025-11-14","current":-11.869655,"twenty":-5.811068,"median":-4.898591,"eighty":-4.08882,"marketCap":1277035540},{"date":"2025-11-21","current":-11.960253,"twenty":-6.69801,"median":-4.937534,"eighty":-4.127114,"marketCap":1306565171},{"date":"2025-11-28","current":-13.338408,"twenty":-7.110152,"median":-4.992317,"eighty":-4.136132,"marketCap":1457117883},{"date":"2025-12-05","current":-13.706211,"twenty":-11.478098,"median":-5.012542,"eighty":-4.13656,"marketCap":1497297545},{"date":"2025-12-12","current":-13.387153,"twenty":-11.950773,"median":-5.056256,"eighty":-4.136846,"marketCap":1462442898},{"date":"2025-12-19","current":-12.474292,"twenty":-12.178774,"median":-5.061679,"eighty":-4.147518,"marketCap":1362719880},{"date":"2025-12-26","current":-14.233544,"twenty":-12.273678,"median":-5.068237,"eighty":-4.154632,"marketCap":1554904531},{"date":"2026-01-02","current":-13.431466,"twenty":-12.335062,"median":-5.068793,"eighty":-4.160323,"marketCap":1467283821},{"date":"2026-01-09","current":-11.698803,"twenty":-12.335062,"median":-5.136174,"eighty":-4.183799,"marketCap":1278003724},{"date":"2026-01-16","current":-14.401935,"twenty":-12.358192,"median":-5.155261,"eighty":-4.187731,"marketCap":1573300040},{"date":"2026-01-23","current":-15.744639,"twenty":-12.45713,"median":-5.171947,"eighty":-4.192073,"marketCap":1719980012},{"date":"2026-01-30","current":-15.624992,"twenty":-12.523037,"median":-5.216176,"eighty":-4.197316,"marketCap":1706909520},{"date":"2026-02-06","current":-13.923348,"twenty":-12.576213,"median":-5.238803,"eighty":-4.205819,"marketCap":1521018069},{"date":"2026-02-13","current":-14.463974,"twenty":-12.717965,"median":-5.287536,"eighty":-4.214018,"marketCap":1580077332},{"date":"2026-02-20","current":-14.366484,"twenty":-12.919201,"median":-5.310162,"eighty":-4.214884,"marketCap":1569427301},{"date":"2026-02-27","current":-15.208444,"twenty":-13.338408,"median":-5.315383,"eighty":-4.240712,"marketCap":1661404842},{"date":"2026-03-06","current":-14.698837,"twenty":-13.396016,"median":-5.355415,"eighty":-4.255652,"marketCap":1605734225},{"date":"2026-03-13","current":-14.507853,"twenty":-13.648603,"median":-5.374559,"eighty":-4.260632,"marketCap":1584870685},{"date":"2026-03-20","current":-18.241416,"twenty":-13.893215,"median":-5.41633,"eighty":-4.275953,"marketCap":1923247264},{"date":"2026-03-27","current":-21.361535,"twenty":-14.059834,"median":-5.48943,"eighty":-4.282885,"marketCap":2252210732},{"date":"2026-04-02","current":-23.696925,"twenty":-14.201638,"median":-5.513424,"eighty":-4.296003,"marketCap":2498437907},{"date":"2026-04-10","current":-29.885474,"twenty":-14.284061,"median":-5.632148,"eighty":-4.323305,"marketCap":3150915147},{"date":"2026-04-17","current":-31.516018,"twenty":-14.426751,"median":-5.771385,"eighty":-4.336613,"marketCap":3322828285},{"date":"2026-04-24","current":-32.251183,"twenty":-14.559692,"median":-6.578962,"eighty":-4.336995,"marketCap":3400338954},{"date":"2026-05-01","current":-32.570171,"twenty":-14.666931,"median":-6.714718,"eighty":-4.368969,"marketCap":3433970886},{"date":"2026-05-08","current":-36.374119,"twenty":-14.779487,"median":-7.118506,"eighty":-4.40896,"marketCap":3835032479},{"date":"2026-05-15","current":-33.151059,"twenty":-15.005487,"median":-11.013542,"eighty":-4.444887,"marketCap":3853943253},{"date":"2026-05-22","current":-30.448133,"twenty":-15.220852,"median":-11.594521,"eighty":-4.464806,"marketCap":3539717207},{"date":"2026-05-29","current":-30.079787,"twenty":-15.26162,"median":-11.787176,"eighty":-4.470498,"marketCap":3496895615},{"date":"2026-06-05","current":-32.31061,"twenty":-15.550545,"median":-11.911508,"eighty":-4.477612,"marketCap":3756237650},{"date":"2026-06-12","current":-35.521957,"twenty":-15.752615,"median":-11.97259,"eighty":-4.48188,"marketCap":4129569555},{"date":"2026-06-18","current":-36.772255,"twenty":-18.655866,"median":-12.082116,"eighty":-4.48188,"marketCap":4274921718},{"date":"2026-06-26","current":-44.943291,"twenty":-19.50544,"median":-12.254757,"eighty":-4.492256,"marketCap":5224837309},{"date":"2026-07-02","current":-48.398471,"twenty":-20.901036,"median":-12.28174,"eighty":-4.533759,"marketCap":5626515902},{"date":"2026-07-10","current":-45.794116,"twenty":-23.696925,"median":-12.328056,"eighty":-4.546056,"marketCap":5323749155},{"date":"2026-07-17","current":-43.080813,"twenty":-28.475782,"median":-12.340203,"eighty":-4.566552,"marketCap":5008316867},{"date":"2026-07-24","current":-47.703285,"twenty":-29.138337,"median":-12.358192,"eighty":-4.57792,"marketCap":5545697686},{"date":"2026-07-31","current":-50.769369,"twenty":-29.924337,"median":-12.387424,"eighty":-4.629142,"marketCap":5902142203},{"date":"2026-08-07","current":-51.059895,"twenty":-30.381727,"median":-12.474292,"eighty":-4.653329,"marketCap":5935916980},{"date":"2026-08-14","current":-53.870179,"twenty":-31.249154,"median":-12.51639,"eighty":-4.666461,"marketCap":7158592655},{"date":"2026-08-21","current":-52.245903,"twenty":-31.638621,"median":-12.55157,"eighty":-4.687203,"marketCap":6942749037}],"updateTime":1787596633548},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ORKA\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630396997","title":"BUZZ-U.S. STOCKS ON THE MOVE -Organon, Verizon, Core Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396997","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396997?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:00","pubTimestamp":1777291248,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE -Organon, Verizon, Core ScientificWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL6N41A0MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","BK0012","LU0234570918.USD","OGN","QCML","LU0289739343.SGD","LU2065171402.SGD","DPZ","QCOM","ADBE","IE0034235295.USD","LU1674673428.USD","LU0859254822.USD","LU0251132253.USD","LU2237443895.HKD","BK4588","LU0256863811.USD","LU0640476718.USD","QCMD","LU0109392836.USD","BK4007","LU0511384066.AUD","ORKA","LU1585245621.USD","300485","LU1496350502.SGD","IE00B1BXHZ80.USD","JPMO","LU2417539215.USD","IE00B19Z9505.USD","VZ","LU2237443622.USD","BK4532","QCMU","BK4528","BK0028","SG9999015978.USD","CORZ","LU0265550359.USD","LU1496350171.SGD","IE000M9KFDE8.USD","BK4604","LU0820562030.AUD","LU0557290698.USD","LU0820561818.USD","ADBG","LU2360032135.SGD","JPO","BK4543","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630037395","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2630037395","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630037395?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:52","pubTimestamp":1777290771,"startTime":"0","endTime":"0","summary":"DarkIris  stock was up 23% in Monday premarket activity after the company said Friday it closed a $3.8 million PIPE financing and a roughly $800,000 content asset acquisition.Oruka Therapeutics  shares were 21% higher after the company said its ORKA-001 phase 2a study showed that 63.5% of participants achieved the primary endpoint and over 80% achieved the secondary endpoints in moderate-to-severe plaque psoriasis.Organon  stock was up 16%, a day after the company and Sun Pharmaceutical Industries said they agreed for Sun to acquire Organon for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation.Qualcomm  shares were 16% higher after a TF International Securities analyst said that industry checks suggest Microsoft-backed  OpenAI is working with Qualcomm and MediaTek to develop smartphone processors.Verizon Communications  stock was up 3% after the company posted higher Q1 adjusted earnings and operating revenue.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MSFT","LU0345769128.USD","LU1988902786.USD","LU2279689827.SGD","LU0157215616.USD","QCMU","LU0964807845.USD","ORKA","IE0004091025.USD","LU0198837287.USD","BK4575","VZ","LU2089283258.USD","LU2125154778.USD","LU2237957902.USD","LU1043141123.HKD","LU1430594728.SGD","IE0001KFT4U8.USD","MSFO","IE00BFSS7M15.SGD","HK0000532082.HKD","BK4579","LU0757359954.USD","LU1323610961.USD","MSFY","BK4504","LU0476273544.USD","LU2111349929.HKD","MSFU","QCMD","LU1803068979.SGD","MSFW","LU2360032135.SGD","LU1852331112.SGD","QCML","QCOM","MSFX","LU0957808578.USD","LU0511384066.AUD","DKI","OGN","LU2047632596.USD","LU2462591350.SGD","IE00BKDWB100.SGD","LU0957791311.USD","MSFD","LU1815336760.USD","LU0683600562.USD","MSFL","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395263","title":"Oruka Therapeutics Shares Gain on Positive Psoriasis-Treatment Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395263","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395263?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:46","pubTimestamp":1777290360,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics shares gained after the company announced positive results for its Phase 2a trial of a psoriasis treatment.The stock jumped 22% to $84 in premarket trading Monday. Through Friday's close, shares had more than doubled this year.The clinical-stage biotechnology company said Monday that Orka-001, a treatment for the skin condition plaque psoriasis, reached the top end of expectations for efficacy, tolerability and the potential for long-lasting response.In a double-blind, placebo-controlled study, 63.5% of patients treated with Orka-001 achieved the primary endpoint at week 16, representing a complete clearing of skin, Oruka said.That data shows higher rates of skin clearance than those of all other inhibitors of that kind for plaque psoriasis, the company said.The drug was also well tolerated with a safety profile similar to that of the placebo and consistent with other treatments of its kind, the company said. There were no serious adverse effects from taking the trea","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ORKA","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630076398","title":"Oruka Therapeutics up 36.2% Premarket After Psoriasis Drug Meets Main Goal of Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2630076398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630076398?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:04","pubTimestamp":1777287847,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0CD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630439840","title":"Oruka Therapeutics' psoriasis drug meets main goal of mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2630439840","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630439840?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:01","pubTimestamp":1777287713,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics' psoriasis drug meets main goal of mid-stage studyApril 27  - Oruka Therapeutics ORKA.O said on Monday that interim results showed its experimental psoriasis drug met the main goal of a mid-stage study.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630398158","title":"Oruka Therapeutics Inc - Orka-001 Shows Favorable Safety Profile Consistent With Il-23P19 Class","url":"https://stock-news.laohu8.com/highlight/detail?id=2630398158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630398158?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA7R0STC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630191398","title":"Oruka Therapeutics Announces Positive Week 16 Data for Orka-001 From the Ongoing Everlast-a Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2630191398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630191398?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA7R0STC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630233389","title":"Oruka Therapeutics to report Week 16 ORKA-001 EVERLAST-A Phase 2a data April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2630233389","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630233389?lang=en_us&edition=fundamental","pubTime":"2026-04-27 00:00","pubTimestamp":1777219233,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics scheduled release of Week 16 data for ORKA-001 from ongoing EVERLAST-A Phase 2a trial in moderate-to-severe plaque psoriasis for April 27, 2026.Conference call and webcast set for 8:00 a.m. ET to discuss trial readout.Update could clarify ORKA-001’s emerging clinical profile in chronic skin disease, a key driver for pipeline valuation and next-stage development plans.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nNDL1glrt6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4112","SG9999014039.USD","BK4585","ORKA","BK4139","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014005.SGD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630841293","title":"Assessing Oruka Therapeutics (ORKA) Valuation After A Sharp Multi Month Share Price Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2630841293","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630841293?lang=en_us&edition=fundamental","pubTime":"2026-04-26 17:07","pubTimestamp":1777194436,"startTime":"0","endTime":"0","summary":"What Is Moving Oruka Therapeutics Stock Right Now\nOruka Therapeutics (ORKA) has caught investor attention after a very strong recent run, with the share price up about 55% over the past month and roughly doubling over the past 3 months.\nSee our latest analysis for Oruka Therapeutics.\nThe recent move builds on strong momentum, with a 55.2% 1 month share price return, a 102.3% 3 month share price return and a roughly 7x 1 year total shareholder return. This suggests investors are reassessing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/assessing-oruka-therapeutics-orka-valuation-after-a-sharp-mu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/assessing-oruka-therapeutics-orka-valuation-after-a-sharp-mu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630827344","title":"Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630827344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630827344?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:20","pubTimestamp":1777062021,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oruka Therapeutics (ORKA) and Praxis Precision Medic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oruka-therapeutics-orka-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oruka-therapeutics-orka-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","ORKA","IE0002141913.USD","BK4581","LU0029874061.USD","IE00B4R5TH58.HKD","HCSG","LU0109394709.USD","BK4137","BK4585","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","LU0128526141.USD","PRAX","IE00BJT1NW94.SGD","XLV","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629055859","title":"ORKA-002 Psoriasis Trial Progress: What Oruka’s New Phase 2 Update Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2629055859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629055859?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:34","pubTimestamp":1776962068,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics, Inc. ($ORKA) announced an update on their ongoing clinical study. Oruka Therapeutics, Inc. is running a mid stage trial called ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/orka-002-psoriasis-trial-progress-what-orukas-new-phase-2-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/orka-002-psoriasis-trial-progress-what-orukas-new-phase-2-update-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA","PRGS","BK4211","BK4097","ISBC","BK4139","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628736781","title":"Oruka Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628736781","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628736781?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:11","pubTimestamp":1776456711,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics will hold its annual stockholder meeting virtually on June 2, 2026.Ballots will cover election of two Class II directors, including Lawrence Klein and Chris Martin.Advisory vote will address compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDLb0r7LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627255262","title":"Oruka Therapeutics CMO Joana Goncalves disposes of shares worth $462,968","url":"https://stock-news.laohu8.com/highlight/detail?id=2627255262","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627255262?lang=en_us&edition=fundamental","pubTime":"2026-04-16 06:46","pubTimestamp":1776293179,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Chief Medical Officer Joana Goncalves reported sales of 7,000 shares on April 15, 2026 at prices ranging from USD 65.73 to USD 67.38.Goncalves also acquired 7,000 shares on April 15, 2026 via option and warrant exercises priced at USD 6.84 and USD 7.8.Directly held common stock totaled 33,377 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL91NrRC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oruka Therapeutics CMO Joana Goncalves disposes of shares worth $462,968","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627862842","title":"Oruka Therapeutics Inc : Wedbush Raises Target Price to $85 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2627862842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627862842?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:16","pubTimestamp":1776251814,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0AV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627468907","title":"Analysts’ Top Healthcare Picks: Oruka Therapeutics (ORKA), Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627468907","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627468907?lang=en_us&edition=fundamental","pubTime":"2026-04-14 02:40","pubTimestamp":1776105611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oruka Therapeutics (ORKA) and Spyre Therapeutics (SY...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-oruka-therapeutics-orka-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-oruka-therapeutics-orka-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","HCSG","BK4585","SY","BK4077","XLV","SYRE","LABU","BK4503","BK4581","BK4139","BK4563","BK4137","LU0029874061.USD","ORKA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627343134","title":"Oruka Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $70 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2627343134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627343134?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:08","pubTimestamp":1776074902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nAZN4SQJ31:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626143732","title":"This Startup's Psoriasis Drug Studies Have Lifted Its Stock -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2626143732","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626143732?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:28","pubTimestamp":1775856480,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics stock doubled in the last month, as investors appreciated the bicoastal startup's lead in ultralong acting drugs against psoriasis.At a recent $59.90, the market values Oruka at $3.1 billion. That's decent, for a company whose first product revenue isn't expected until 2030. But Big Pharma has been acquisitive lately, as it seeks to stock its pipeline with developmental drugs aimed at growing market categories.Psoriasis and other autoimmune disorders are one of those categories. Skyrizi is a $21 billion a year seller for AbbVie, and is growing 30% annually. Despite Skyrizi's popularity, newer psoriasis drugs are also enjoying fast-growing sales, including Johnson & Johnson's Tremfya and Belgium-based UCB's Bimzelx. Along with these injectable drugs, there are pills like Amgen's Otezla.This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published indepe","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","IE00BGHQF631.EUR","LU2129689605.HKD","IE00B19Z3581.USD","BK4588","LU0203345920.USD","BK4566","LU0289739343.SGD","IE00BLSP4452.SGD","LU1934455194.USD","LU1267930573.SGD","LU1061106388.HKD","LU0098860793.USD","IE00BDGV0183.EUR","AMGN","LU0289961442.SGD","ORKA","LU0320765646.SGD","LU1989771016.USD","LU2468319806.SGD","IE0002270589.USD","LU0820561818.USD","LU0320765992.SGD","LU0069063385.USD","LU1551013425.SGD","LU0289739699.SGD","LU1732800096.USD","LU2129689514.USD","LU2237443978.SGD","ABBV","LU0661504455.SGD","LU1244550577.SGD","LU1496350502.SGD","IE00B2B36J28.USD","BK4534","LU0965509283.SGD","LU2242652126.USD","LU2133065610.SGD","LU2237443549.SGD","BK4585","LU1037948897.HKD","LU0943347566.SGD","LU0553294199.USD","IE00B19Z3B42.SGD","LU0057025933.USD","LU0122379950.USD","LU0472753341.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625334149","title":"Analysts Are Bullish on These Healthcare Stocks: Cannara Biotech (LOVFF), Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625334149","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625334149?lang=en_us&edition=fundamental","pubTime":"2026-04-07 16:11","pubTimestamp":1775549506,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cannara Biotech (LOVFF) and Oruka Therapeutics (ORKA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-cannara-biotech-lovff-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-cannara-biotech-lovff-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LOVFF","LABU","BK4588","ORKA","BLSG","LU0029874061.USD","BLSX","BK4137","BK4139","BK4007","BK4183","BK4585","BK4112","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625671928","title":"UBS Sticks to Its Buy Rating for Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625671928","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625671928?lang=en_us&edition=fundamental","pubTime":"2026-04-06 20:36","pubTimestamp":1775478977,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Yee from UBS maintained a Buy rating on Oruka Therapeutics, with a price target of $75.00. According to TipRank...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-its-buy-rating-for-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-its-buy-rating-for-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625462811","title":"Does Oruka Therapeutics' (ORKA) $1 Billion Shelf Plan Reframe Its Long-Term Capital Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625462811","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625462811?lang=en_us&edition=fundamental","pubTime":"2026-04-06 03:21","pubTimestamp":1775416898,"startTime":"0","endTime":"0","summary":"In early April 2026, Oruka Therapeutics, Inc. filed an omnibus shelf registration that would allow it to issue up to US$1 billion of common stock, preferred stock, depositary shares, and warrants over time.\nThis broad financing framework gives Oruka Therapeutics flexible access to multiple types of capital, which could be used for future clinical, operational, or transactional initiatives.\nNext, we’ll examine how this flexible US$1 billion shelf registration may influence Oruka Therapeutics’...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/does-oruka-therapeutics-orka-1-billion-shelf-plan-reframe-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/does-oruka-therapeutics-orka-1-billion-shelf-plan-reframe-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":116,"code":"91000000","status":"200"}]}}